🇺🇸 FDA
Pipeline program

AB-836

AB-836-001

Phase 1 small_molecule terminated

Quick answer

AB-836 for Chronic Hepatitis is a Phase 1 program (small_molecule) at Arbutus Biopharma Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Arbutus Biopharma Corp
Indication
Chronic Hepatitis
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials